CIK 0000872912
- Non-accelerated filer
- Smaller reporting company
DELCATH SYSTEMS, INC.
Sign in to watch- Ticker
- DCTH
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 061245881
- Phone
- +1 518-743-8892
- Business address
- 566 QUEENSBURY AVENUE, QUEENSBURY, NY, 12804
- Former names
- DELCATH SYSTEMS, INC., DELCATH SYSTEMS INC
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 32,680 shares (grant or award)
- 4 Grant or award Director acquired 32,680 shares (grant or award)
- 4 Grant or award Director acquired 32,680 shares (grant or award)
- 4 Grant or award Director acquired 32,680 shares (grant or award)
- 4 Grant or award Director acquired 32,680 shares (grant or award)
- 4 Grant or award Director acquired 49,020 shares (grant or award)
- 4 Open-market buy Director bought 7,500 shares at $1.57 ($11,762)
- 4 Open-market buy Director bought 65,000 shares at an average $1.51 ($98,050)
- 4 Open-market buy Director bought 50,000 shares at $1.51 ($75,275)
- 4 Open-market buy Director bought 66,667 shares at an average $1.49 ($99,454)
- 4 Open-market buy EVP Reg. Affairs/Quality Assur bought 5,000 shares at $1.49 ($7,450)
- 4 Open-market buy President and CEO bought 7,000 shares at $1.52 ($10,611)
- 4 Open-market buy Exec. VP, Global Marketing bought 3,000 shares at $1.49 ($4,470)
- 4 Open-market buy Exec. V.P., CFO bought 20,000 shares at an average $1.50 ($30,000)
- 4 Grant or award Exec. VP, Global Marketing acquired 7,500 shares (grant or award)
- 3 Insider Initial Statement of Ownership
Page 15 of 30 · 595 filings